Investors

Investors

Investors

Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash c...

Learn More

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

– Update on FDA Inspection of Buena Facility – Assessing New Growth Opportunities in Injectables – Conference Call to Be...

Learn More

Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021

BUENA, N.J. , Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jer...

Learn More
See All News

Events

More

Investor Overview

There are no items to display.

Stock Information

Change
Volume
52 Week High
52 Week Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.


Full Quote